Good morning,
If you’re new to the newsletter, welcome. To our regular readers, thank you — we’d love to hear your feedback.
In today's edition:
- Berlin secures €100 million financing for a cell and gene therapy hub
- Healthcare-led logistics asset changes hands in Leipzig
- 🔒 €100 million pharma manufacturing expansion near Barcelona
- 🔒 Cellares pre-lets entire Nexus building at Leiden Bio Science Park
- 🔒 Healthcare materials group leases logistics space in southern Germany
- 🔒 Medtech firm takes lab space in Oxford
- 🔒 Exeter welcomes new biotech firm
- 🔒 Construction progress at Oxford Technology Park
- 🔒 Development uncertainty over planned lab project in Hamburg
(🔒 = for paying members only. Subscribe here to unlock).
— Stephen Ryan (connect with me on LinkedIn)
1. Berlin: €100 million financing for cell and gene therapy hub
In Q4 2025, iQ spaces and UBS Asset Management secured project financing exceeding €100 million from Haspa Hamburger Sparkasse for the Berlin Center for Gene and Cell Therapies (Berlin CGT) with a total project volume of approximately €200 million.
The Berlin CGT project will comprise a ten-storey laboratory and innovation centre spanning approximately 20,000 sq m in Berlin-Mitte, near the main railway station and Charité Campus.
The development, part of the Bayer Open Innovation Campus, is scheduled for completion in 2028. Pre-let space totals 15,000 sq m to tenants including the Bayer Co.Lab, Gene and Cell Therapies Incubator Berlin and Charité.
Why it matters: flagship deal shows German banks will back de-risked labs.
🔍 Need deeper insight into life sciences real estate?
In addition to this newsletter, we deliver bespoke research and strategic analysis for investors and developers — from acquisition support to market mapping and custom reporting.
Get in touch to discuss your next project.
2. Leipzig: EQT Exeter acquires healthcare-led logistics via sale-and-leaseback
EQT Exeter acquired a newly completed 40,000 sq m multi-user logistics centre in Borna-Ost near Leipzig from Fiege Real Estate in late summer 2025 through a sale-and-leaseback transaction.
The facility, situated on an 80,000 sq m site with direct access to the A72 motorway, comprises four warehouse units.
Fiege remains as long-term tenant and operator of the multi-user logistics centre, which it currently operates primarily for customers from the healthcare sector (including pharmaceuticals and medical technology products).
Why it matters: healthcare‑weighted logistics continues to attract institutional capital.
👇 As a free member, you’re only seeing 2 of 9 deals this week.
Subscribers see them all so why not take a 14-day trial?
